Key Financial Figures (₹ in lakh)

Quarter ended June 30, 2026 (Unaudited):

  • Revenue from operations: 4,399.67
  • Other income: 45.00
  • Total Income: 4,444.67
  • Total Expenses: 4,180.30
  • Profit before tax: 264.37
  • Tax expense:
  • Current tax: 25.18
  • Deferred tax: 34.67
  • Short/(Excess) provision of earlier years: -
  • Profit for the period: 204.52
  • Total Comprehensive Income: 204.52
  • Earnings Per Share (Basic & Diluted): ₹1.47

Comparative Figures:

  • Quarter ended June 30, 2025 (Unaudited): Profit of ₹247.50 lakh, EPS ₹1.78
  • Quarter ended March 31, 2026 (Audited): Profit of ₹40.01 lakh, EPS ₹0.29
  • Year ended March 31, 2026 (Audited): Profit of ₹840.93 lakh, EPS ₹6.06

Expense Breakdown (Q1 FY27):

  • Cost of Materials consumed: 2,383.17
  • Purchases of stock-in-trade: 323.63
  • Changes in inventories: (121.43)
  • Employee benefits expense: 419.35
  • Finance costs: 10.79
  • Depreciation & amortisation: 152.99
  • Other expenses: 1,011.80

Capital Structure

  • Paid-up equity share capital: ₹1,387.67 lakh (Face Value per share ₹10)
  • Reserves excluding Revaluation Reserves: ₹7,769.66 lakh (as of March 31, 2026)

Operational and Regulatory Details

  • The company operates in a single segment: manufacturing & sales of transfusion solutions in bottles.
  • The company does not have any subsidiary or associate.
  • Figures for the quarter ended March 31, 2026 represent balancing figures between audited annual figures and unaudited year-to-date figures for the nine months ended December 31, 2025.
  • The company disclosed ongoing assessment of financial impact from newly notified Labour Codes, primarily affecting gratuity and privilege leave provisions based on ICAI guidance.

Debt and Default Status

  • Total outstanding loans from banks/financial institutions: ₹0 crore
  • Amount of default on loans: ₹0 crore
  • Unlisted debt securities outstanding: ₹0 crore
  • Amount of default on debt securities: ₹0 crore
  • Total financial indebtedness: ₹0 crore

Auditor Review

Shah & Shah Associates, Chartered Accountants (FRN 113742W), issued an unmodified review report stating that nothing has come to their attention suggesting material misstatement in the financial results. The review was conducted under SRE 2410 issued by ICAI.

Meeting Details

The Board meeting commenced at 10:00 a.m. and concluded at 1:40 p.m. on August 13, 2026.